학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 44건 | 목록
1~20
Academic Journal
Arrizabalaga, L; Di Trani, CA; Fernández-Sendin, M; Bella, Á; Russo-Cabrera, JS; Gomar, C; Ardaiz, N; Belsue, V; González-Gomariz, J; Zalba, S; Gil-Korilis, A; Garrido, MJ; Melero, I; Aranda, F; Berraondo, P
J Nanobiotechnology
Journal of Nanobiotechnology, Vol 23, Iss 1, Pp 1-15 (2025)
Journal of Nanobiotechnology, Vol 23, Iss 1, Pp 1-15 (2025)
Academic Journal
Di Trani, Claudia Augusta; Cirella, Assunta; Arrizabalaga, Leire; Alvarez, Maite; Bella, Angela; Fernandez-Sendin, Myriam; Russo-Cabrera, Joan Salvador; Gomar, Celia; Ardaiz, Nuria; Teijeira, Alvaro; Bolanos, Elixabet; Gonzalez-Gomariz, Jose; Otano, Itziar; Aranda, Fernando; Palencia, Belen; Segues, Aina; Huang, Shuyu; van Duijnhoven, Sander M. J.; van Elsas, Andrea; Melero, Ignacio; Berraondo, Pedro
Academic Journal
Gomar, C.; Di Trani, C.A.; Bella, A.; Arrizabalaga, L.; Gonzalez-Gomariz, J.; Fernandez-Sendin, M.; Alvarez, M.; Russo-Cabrera, J.S.; Ardaiz, N.; Aranda, F.; Melero, I.; Berraondo, P.; Schippers, T.; Orlinger, K.K.; Lauterbach, H.; Quintero, M.
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 16 April 2024, 12(4))
Academic Journal
Bella, A.; Arrizabalaga, L.; Di Trani, C.A.; Gonzalez-Gomariz, J.; Gomar, C.; Russo-Cabrera, J.S.; Olivera, I.; Cirella, A.; Fernandez-Sendin, M.; Alvarez, M.; Teijeira, A.; Melero, I.; Aranda, F.; Berraondo, P.; Atay, C.; Medina-Echeverz, J.; Hinterberger, M.; Hochrein, H.
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 2 November 2023, 11(11))
Academic Journal
Cirella, A.; Bolaños, E.; Di Trani, C.A.; Sánchez-Gregorio, S.; Etxeberria, I.; Gonzalez-Gomariz, J.; Olivera, I.; Glez-Vaz, J.; Luri-Rey, C.; Azpilikueta, A.; Rodríguez, I.; Fernandez-Sendín, M.; Egea, J.; Eguren, I.; Sanmamed, M.F.; Palencia, B.; Teijeira, A.; Berraondo, P.; Melero, I.; de Andrea, C.E.; Brocco, D.
In: Cancer Immunology Research . (Cancer Immunology Research, February 2023, 11(2):184-194)
Academic Journal
Di Trani, C.A.; Cirella, A.; Arrizabalaga, L.; Bella, Á.; Fernandez-Sendin, M.; Russo-Cabrera, J.S.; Gomar, C.; Olivera, I.; Bolaños, E.; González-Gomariz, J.; Álvarez, M.; Etxeberria, I.; Palencia, B.; Teijeira, Á.; Melero, I.; Berraondo, P.; Aranda, F.
In: OncoImmunology . (OncoImmunology, 2023, 12(1))
Academic Journal
Bella, Á.; Arrizabalaga, L.; Di Trani, C.A.; Cirella, A.; Fernandez-Sendin, M.; Gomar, C.; Russo-Cabrera, J.S.; Rodríguez, I.; González-Gomariz, J.; Alvarez, M.; Teijeira, Á.; Melero, I.; Berraondo, P.; Aranda, F.; Medina-Echeverz, J.; Hinterberger, M.; Hochrein, H.
In: OncoImmunology . (OncoImmunology, 2022, 11(1))
Academic Journal
Di Trani, C.A.; Fernandez-Sendin, M.; Cirella, A.; Olivera, I.; Bolaños, E.; Melero, I.; Berraondo, P.; Segués, A.
In: Expert Opinion on Drug Discovery . (Expert Opinion on Drug Discovery, 2022, 17(1):41-53)
Academic Journal
Alvarez, M.; Molina, C.; Fernandez-Sendin, M.; Gonzalez-Gomariz, J.; Ochoa, M.C.; Teijeira, A.; Glez-Vaz, J.; Aranda, F.; Sanmamed, M.F.; Berraondo, P.; Melero, I.; De Andrea, C.E.; Villalba, M.; Rodriguez-Ruiz, M.E.; Fan, X.; Shen, W.H.; Quintero, M.
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 25 November 2021, 9(11))
Academic Journal
Tenesaca, S.; Vasquez, M.; Alvarez, M.; Otano, I.; Fernandez-Sendin, M.; Di Trani, C.A.; Ardaiz, N.; Gomar, C.; Bella, A.; Aranda, F.; Melero, I.; Berraondo, P.; Medina-Echeverz, J.
In: Journal for ImmunoTherapy of Cancer . (Journal for ImmunoTherapy of Cancer, 28 July 2021, 9(7))
Academic Journal
Fernandez-Sendin, M.; Di Trani, C.A.; Bella, A.; Vasquez, M.; Ardaiz, N.; Gomar, C.; Arrizabalaga, L.; Aranda, F.; Berraondo, P.; Ciordia, S.; Corrales, F.J.
In: Frontiers in Immunology . (Frontiers in Immunology, 23 February 2021, 11)
Academic Journal
Ardaiz, N.; Gomar, C.; Vasquez, M.; Tenesaca, S.; Fernandez-Sendin, M.; Di Trani, C.A.; Belsué, V.; Berraondo, P.; Escalada, J.; Werner, U.; Tennagels, N.
In: Frontiers in Pharmacology . (Frontiers in Pharmacology, 19 February 2021, 11)
Academic Journal
Tenesaca, S.; Vasquez, M.; Fernandez-Sendin, M.; Di Trani, C.A.; Ardaiz, N.; Gomar, C.; Cuculescu, D.; Alvarez, M.; Otano, I.; Melero, I.; Berraondo, P.
In: Molecular Nutrition and Food Research . (Molecular Nutrition and Food Research, 1 August 2020, 64(15))
Academic Journal
Vasquez, M.; Jimenez, A.; Tenesaca, S.; Fernandez-Sendin, M.; Gomar, C.; Ardaiz, N.; Di Trani, C.A.; Casares, N.; Lasarte, J.J.; Berraondo, P.; Consuegra-Fernández, M.; Aranda, F.; Lozano, F.
In: Journal of Immunology . (Journal of Immunology, 1 August 2019, 203(3):696-704)
Academic Journal
Ochoa, M.C.; Minute, L.; Zabaleta, A.; Fernandez-Sendin, M.; Sanmamed, M.F.; Paiva, B.; Berraondo, P.; Melero, I.; Oñate, C.; Perez, G.; Rodriguez, I.; Alignani, D.; Lopez, A.; Perez-Ruiz, E.; Muntasell, A.; Lopez-Botet, M.
In: OncoImmunology . (OncoImmunology, 3 July 2019, 8(7))
Academic Journal
Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Luri-Rey C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Teijeira A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Department of oncology, Clinica Universidad de Navarra, Madrid, Spain.; Olivera I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Bolaños E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Castañón E; Department of oncology, Clinica Universidad de Navarra, Madrid, Spain.; Palencia B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Brocco D; Department of Pharmacy, University 'G. D'Annunzio' Chieti-Pescara, Chieti, Italy.; Fernández-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain.; Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Department of oncology, Clinica Universidad de Navarra, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain; Department of Immunology and immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain. Electronic address: imelero@unav.es.
Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther Subsets: MEDLINE
Academic Journal
Dunai C; Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom.; Ames E; Department of Pathology, Stanford University, Stanford, CA, United States.; Ochoa MC; Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Fernandez-Sendin M; Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Melero I; Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Simonetta F; Division of Hematology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland; Translational Research Centre in Onco-Haematology, Faculty of Medicine, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.; Baker J; Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, United States.; Alvarez M; Program for Immunology and Immunotherapy, CIMA, Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Electronic address: malvarezr@unav.es.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101475846 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1937-6448 (Print) Linking ISSN: 19376448 NLM ISO Abbreviation: Int Rev Cell Mol Biol Subsets: MEDLINE
Academic Journal
Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Fernandez-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Bella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Electronic address: pberraondol@unav.es.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101475846 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1937-6448 (Print) Linking ISSN: 19376448 NLM ISO Abbreviation: Int Rev Cell Mol Biol Subsets: MEDLINE
Academic Journal
Bella Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain. Electronic address: abellacarre@unav.es.; Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Fernández-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Teijeira A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Translational Oncology Group, Program in Solid Tumors, Cima Universidad de Navarra, Pamplona, Spain; Department of Immunology and Immunotherapy, Clinica Universidad de Navarra, Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain. Electronic address: faranda@unav.es.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101475846 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1937-6448 (Print) Linking ISSN: 19376448 NLM ISO Abbreviation: Int Rev Cell Mol Biol Subsets: MEDLINE
Academic Journal
Bella Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Fernández-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Arrizabalaga L; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Teijeira Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Medina-Echeverz J; Bavarian Nordic GmbH, Fraunhoferstrasse 13, 82152 Planegg, Germany.; Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Department of Oncology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Fernandez-Sendin, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어